Effectiveness of fibroblast growth factor 23 lowering modalities in chronic kidney disease: a systematic review and meta-analysis
Kullaya Takkavatakarn, Thunyatorn Wuttiputhanun, Jeerath Phannajit, Kearkiat Praditpornsilpa, Somchai Eiam‐Ong, Paweena Susantitaphong
Topics & Concepts
MedicineSevelamerFibroblast growth factor 23Kidney diseaseMeta-analysisInternal medicineSecondary hyperparathyroidismDialysisPhosphate binderParathyroidectomyNephrologyUrologyRandomized controlled trialEndocrinologyParathyroid hormoneHyperphosphatemiaCalciumParathyroid Disorders and TreatmentsMagnesium in Health and DiseaseFibroblast Growth Factor Research